186 related articles for article (PubMed ID: 9024708)
1. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
3. Identification of p53 gene mutations in breast cancers and their effects on transcriptional activation function.
Oh SJ; Jung JY; Shim SS; Im MY; Kim HD; Chung SY; Yoon JH
Mol Cells; 2000 Jun; 10(3):275-80. PubMed ID: 10901165
[TBL] [Abstract][Full Text] [Related]
4. Expression of p21(WAF1) and p53 and polymorphism of p21(WAF1) gene in gastric carcinoma.
Xie HL; Su Q; He XS; Liang XQ; Zhou JG; Song Y; Li YQ
World J Gastroenterol; 2004 Apr; 10(8):1125-31. PubMed ID: 15069711
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens from non-transition and transition zones.
Takayama H; Shin M; Nonomura N; Okuyama A; Aozasa K
Jpn J Cancer Res; 2000 Sep; 91(9):941-7. PubMed ID: 11011123
[TBL] [Abstract][Full Text] [Related]
6. Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.
Gruel N; Benhamo V; Bhalshankar J; Popova T; Fréneaux P; Arnould L; Mariani O; Stern MH; Raynal V; Sastre-Garau X; Rouzier R; Delattre O; Vincent-Salomon A
Breast Cancer Res; 2014 May; 16(3):R46. PubMed ID: 24887297
[TBL] [Abstract][Full Text] [Related]
7. Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest.
Waggoner SA; Johannes GJ; Liebhaber SA
J Biol Chem; 2009 Apr; 284(14):9039-49. PubMed ID: 19211566
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.
Ireland AP; Shibata DK; Chandrasoma P; Lord RV; Peters JH; DeMeester TR
Ann Surg; 2000 Feb; 231(2):179-87. PubMed ID: 10674608
[TBL] [Abstract][Full Text] [Related]
9. Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand.
Thongsuksai P; Boonyaphiphat P; Puttawibul P; Sudhikaran W
World J Gastroenterol; 2010 Nov; 16(42):5359-66. PubMed ID: 21072901
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
Dewald GW; Smyrk TC; Thorland EC; McWilliams RR; Van Dyke DL; Keefe JG; Belongie KJ; Smoley SA; Knutson DL; Fink SR; Wiktor AE; Petersen GM
Mayo Clin Proc; 2009 Sep; 84(9):801-10. PubMed ID: 19720778
[TBL] [Abstract][Full Text] [Related]
11. Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.
Kanovsky M; Raffo A; Drew L; Rosal R; Do T; Friedman FK; Rubinstein P; Visser J; Robinson R; Brandt-Rauf PW; Michl J; Fine RL; Pincus MR
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12438-43. PubMed ID: 11606716
[TBL] [Abstract][Full Text] [Related]
12. Difference in allelic expression of genes probably associated with tumor progression in murine fibrosarcomas and cell lines.
Ohtsuka H; Mafune Y; Tsunashima K; Takahashi H; Kominami R
Jpn J Cancer Res; 1994 Oct; 85(10):1015-22. PubMed ID: 7961103
[TBL] [Abstract][Full Text] [Related]
13. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
[TBL] [Abstract][Full Text] [Related]
14. Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas.
Goto A; Kanda H; Ishikawa Y; Matsumoto S; Kawaguchi N; Machinami R; Kato Y; Kitagawa T
Jpn J Cancer Res; 1998 May; 89(5):539-47. PubMed ID: 9685858
[TBL] [Abstract][Full Text] [Related]
15. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Suzuki Y; Tamura G; Satodate R; Fujioka T
Jpn J Cancer Res; 1992 Mar; 83(3):233-5. PubMed ID: 1582882
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
Iacobuzio-Donahue CA; Maitra A; Shen-Ong GL; van Heek T; Ashfaq R; Meyer R; Walter K; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Am J Pathol; 2002 Apr; 160(4):1239-49. PubMed ID: 11943709
[TBL] [Abstract][Full Text] [Related]
17. Gene mutation analysis and quantitation of DNA topoisomerase I in previously untreated non-small cell lung carcinomas.
Takatani H; Oka M; Fukuda M; Narasaki F; Nakano R; Ikeda K; Terashi K; Kinoshita A; Soda H; Kanda T; Schneider E; Kohno S
Jpn J Cancer Res; 1997 Feb; 88(2):160-5. PubMed ID: 9119744
[TBL] [Abstract][Full Text] [Related]
18. p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.
Nasir A; Ahmed MK; Saller JJ; Henderson-Jackson EB; Malafa MP; Yeatman TJ; Coppola D
Cancer Genomics Proteomics; 2023; 20(6):522-530. PubMed ID: 37889062
[TBL] [Abstract][Full Text] [Related]
19. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Jones S; Zhang X; Parsons DW; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Kamiyama H; Jimeno A; Hong SM; Fu B; Lin MT; Calhoun ES; Kamiyama M; Walter K; Nikolskaya T; Nikolsky Y; Hartigan J; Smith DR; Hidalgo M; Leach SD; Klein AP; Jaffee EM; Goggins M; Maitra A; Iacobuzio-Donahue C; Eshleman JR; Kern SE; Hruban RH; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
Science; 2008 Sep; 321(5897):1801-6. PubMed ID: 18772397
[TBL] [Abstract][Full Text] [Related]
20. Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.
Lozano-Leon A; Perez-Quintela BV; Iglesias-García J; Lariño-Noia J; Varo E; Forteza J; Domínguez-Muñoz JE
Oncol Lett; 2011 Jan; 2(1):161-166. PubMed ID: 22870146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
